CDx Boston reveals the most exciting clinical and commercial results and addresses the most pressing challenges facing CDx development right now, with the world’s leading drug and Dx developers.
More and more drug developers are seeking to achieve successful and effective companion diagnostic development to cement their position in the ‘personalized’ future. High profile collaborations with Dx companies have been key in advancing the field in recent years. But there are still questions around what makes a successful companion diagnostic development strategy. For example…
How to reduce clinical attrition by using biomarkers and the latest technology platforms more effectively?
How to overcome market access hurdles in the face of regulatory and reimbursement uncertainty?
and of course how to form the most effective partnerships, in order to share risk, increase chances of success and get to market faster?
World CDx Boston brings you exclusive insights, novel case studies and cutting-edge solutions from those at the forefront of personalized medicine. This unique collection of industry leaders will address the most pressing challenges, both at lab-phase and at market level. You will leave the meeting with the tools and knowledge you need to reduce clinical attrition, achieve successful commercialization and claim your place as a CDx market leader, now.
Why attend World CDx Boston?
“This was a great conference with outstanding speakers. They gave an up to date view of all aspects and issues concerning companion Dx development” Transgene
“Expertise from thought leaders is rarely so freely given, or as earnestly debated” CHI Center for Translational Research
2. Get to market faster
"A valuable resource for learning from case studies and keeping up with current policies and regulations. Also a great opportunity for connecting the needs of biotech and pharma with diagnostic companies" Merrimack
3. Maximize the effectiveness of your partnership
“High quality attendees generates a good opportunity to network” Abbott
“Outstanding meeting with first class speakers. I learned a lot and I will certainly recommend the meeting to my colleagues…” Sanofi Aventis
“Action Packed!” Millennium Pharmaceuticals
“Successful in bringing together pharma and diagnostics for information sharing, discussion and networking. Very informative, good representation, great networking.” Abbott Molecular
This was a well organised and productive meeting with relevant topics pertaining to companion diagnostics and many opportunities to network with others in the field. Thank you!” Johnson & Johnson